Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-006842
Filing Date
2025-03-10
Accepted
2025-03-10 16:32:40
Documents
113
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K urgn20241231_10k.htm   iXBRL 10-K 2272606
2 EXHIBIT 4.2 ex_786027.htm EX-4.2 57904
3 UROGEN PHARMA LTD. INSIDER TRADING POLICY ex_786013.htm EX-19.1 37177
4 EXHIBIT 23.1 ex_727428.htm EX-23.1 2304
5 EXHIBIT 31.1 ex_727429.htm EX-31.1 13987
6 EXHIBIT 31.2 ex_727430.htm EX-31.2 13972
7 EXHIBIT 32.1 ex_727431.htm EX-32.1 7087
13 yepieline03052025.jpg GRAPHIC 80441
  Complete submission text file 0001437749-25-006842.txt   10320747

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA urgn-20241231.xsd EX-101.SCH 92854
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20241231_cal.xml EX-101.CAL 63701
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20241231_def.xml EX-101.DEF 587114
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20241231_lab.xml EX-101.LAB 510077
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20241231_pre.xml EX-101.PRE 637519
116 EXTRACTED XBRL INSTANCE DOCUMENT urgn20241231_10k_htm.xml XML 1459867
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38079 | Film No.: 25724249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)